Marie Kostine

Rheumatologist and PhD training with a special interest in immuno-oncology.

[Marie Kostine @MarieKostine]

@charles_cazanav @CHUBordeaux @LaureBarthod @yannbubien @LahouatiM @univbordeaux A rheum star ⭐️ is born!

[Marie Kostine @MarieKostine]

@DrJESalem @CircAHA @AngoulvantD @AtulPathak31 @FRoubille @Reseau_CRPV @CautelaJennifer @Nahema_Issa!

[DrJE-Salem @DrJESalem]

Le type de troponine (I ou T) et les seuils pour stratifier les risques dans les #myocardites à l'#immunothérapie publié dans notre article paru @CircAHA https://t.co/h6y5GOnbA4 @SABOURETCardio @AngoulvantD @AtulPathak31 @FRoubille @Reseau_CRPV @MarieKostine @CautelaJennifer

[David Liew @drdavidliew]

For our rheum patients who have had cancer previously - the default can’t be to not have DMARDs.

@eular_org points to consider SLR:
no clear risk, across b/tsDMARDs

For too long these patients were unnecessarily asked to ride it out. No more please

POS1069 #EULAR2023 @RheumNow

[David Liew @drdavidliew]

Great to meet pre-#EULAR2023 in person with fantastic rheumatic immune-related adverse events colleagues today.

We keep working towards classification criteria, so we can get better treatments for our patients. Thanks to many great folks tagged, & led by @MarieKostine @lexmeara

[Marie Kostine @MarieKostine]

@charles_cazanav @CHUBordeaux @librairiemollat @FantineEtHippo @yannbubien @AmandineMrto @gusoulard @sebastien_gard @LahouatiM @LaureBarthod #autresunsetdujour @charles_cazanav A toi de deviner le lieu 😉

[Marie Kostine @MarieKostine]

@m_scherlinger @NaturePortfolio 👏👏👏

[Leonard Calabrese @LCalabreseDO]

Big step in a highly complex area of checkpoint agonists-many more targets of interest from preclinical models PD-1 agonist generates ‘a bit of excitement’ in RA @MaxKonigMD @drdavidliew @CCalabreseDO @jeffsparks @MarieKostine https://t.co/rSXR2R37r0

[Marie Kostine @MarieKostine]

Exciting project and fantastic team!

[José A. Gómez Puerta @DrGomezPuerta]

Starting an exciting project defining
@ACRheum/@eular_org
classification criteria for Rheumatic irAEs with colleagues from around the world
@drdavidliew @lexmeara @MarieKostine @cappelliMD
@CCalabreseDO @msalmazor among others
#ACR2022

[NatRevRheumatol @NatRevRheumatol]

#NovemberIssue | Read about immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases in this #Review

https://t.co/1YuAKpzGwq

[Janet Pope @Janetbirdope]

@drdavidliew will always inform and give a balanced view as well as his honest opinion. Follow him and others @rheumnow for coverage of #ACR22

[Nilasha Ghosh @NilashaGhosh]

Congrats to the OMERACT irAE working group! First step of many to develop outcomes for ICI-induced arthritis patients! @RheumDr_Nina @MarieKostine @lovetolearn27 @got_rheum @cappelliMD @CCalabreseDO @

[Marie Kostine @MarieKostine]

Fantastic team!

[OMERACT @OMERACT]

Check out the latest publication from the OMERACT Immune Related Adverse Events Working Group: Identification of Outcome Domains in Immune Checkpoint Inhibitor-Induc... https://t.co/XlTmlfq1fq @lexmeara @NilashaGhosh @drdavidliew

[NatRevRheumatol @NatRevRheumatol]

Our #NovemberIssue is out now! Read about the role of #mitochondria in rheumatic diseases, immune-checkpoint inhibitors in patients with pre-existing #autoimmunity and sexual dimorphism in axial #spondyloarthritis

https://t.co/cVb9OrdsMB

[RESO Bordeaux @RESOBordeaux]

🗓️#SaveTheDate : La 4e Journée @RESOBordeaux aura lieu le 9 mars 2023 !
Au programme : l’actualité de la recherche du #lupus, des #myosites et de la #sclérodermie ainsi qu’une session spéciale maladies auto-inflammatoires.
https://t.co/d7QxgqhyvS
#maladieautoimmune #rhumatologie

[ESMO - Eur. Oncology @myESMO]

Updated📢 Management of toxicities from #immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment & follow-up. W/ recommended assessment & tx algorithms according to grade of toxicity
https://t.co/e6v6jbs4OY
@HaanenJohn @wick_wolfgang @peters_solange @MarieKostine

[Cassandra Calabrese @CCalabreseDO]

join us Feb 9-10,2023, 4th annual Management of Checkpoint Inhibitor Related Toxicity conference @FunchainMD @jamecancerdoc @cappelliMD @drdavidliew @lovetolearn27 @jeffsparks @NilashaGhosh @ReidMDMPH @afreenshariffmd @DrRohitMoudgil @AliMehdiMD @DrEstfan https://t.co/gbRKqvHOYF

[Marie Kostine @MarieKostine]

Very proud to share this review article freshly off the press in @NatRevRheumatol. Opportunities and challenges of #ICI in patients with pre-existing #autoimmune disease. Still so much to learn! @CHUBordeaux @ChuBrest @HopitalEuropeen @RESOBordeaux

https://t.co/22O91WFs4I

[Marie Kostine @MarieKostine]

@GuillotinVivien @charles_cazanav @CHUBordeaux @univbordeaux @Villedepessac @yannbubien @RaynalPessac @MathieuMolimard @peyo3319 @Genevieve_Hery @celine_etchetto @LaureBarthod @DucoursMailys @sfazileblanc Haha @charles_cazanav tu aurais aussi du masquer les boucles d’oreille 😂

[Marie Kostine @MarieKostine]

@charles_cazanav @ce_medinterne @CHUBordeaux @yannbubien @LaureBarthod @ReJIF_ @YLST29 La #rhumatologie est aussi dans la top liste des fans du service d’#infectiologie du Pr @charles_cazanav 🤝🤩